Liquidators of biotech startup in talks over stake in drug firm

Synthase Biotech's trademarked enzyme Aloxsyn had been shown to improve the ability of cows to conceive. (Image: Unsplash)

Riley Kennedy

Thu, 23 Jan 2025

Liquidators of a collapsed animal-breeding startup are in talks about its stake in another drug development company.Set up in 2015, Synthase Biotech had developed a plant-based enzyme that stopped fats from going rancid.The Waikato-based company, which leased premises at AgResearch’s Ruakura campus in Hamilton, initially targeted artificial insemination for the global dairy industry and undertook its first capital raise of $800,000 in 2016.However, it collapsed in June last year after failing to find enough commercial contracts for its pr...

Subscribe to BusinessDesk

Stay informed on business, government and financial developments across New Zealand.

Deeply researched, twice-edited and fact-checked news
Annual subscribers also receive a complimentary subscription to The Wall Street Journal
Personalised email news alerts, plus gift up to 5 stories a month to non-subscribers

You can cancel anytime.

We are serious about journalism.

Already a Subscriber ? Sign in here.

Name {{ registerForm.errors.get('name') }}

Email address {{ registerForm.errors.get('email') }}

Phone Number {{ registerForm.errors.get('phone') }}

Job Title {{ registerForm.errors.get('title') }}

Password Minimum password length of 8 characters.
Require at least one upper and lowercase, numeric, and special character. {{ registerForm.errors.get('password') }}

Repeat password {{ registerForm.errors.get('password_confirmation') }}

We had trouble validating your card. It's possible your card provider is preventing us from charging the card. Please contact your card provider or customer support.

Credit Card

Cardholder's name

{{ __(plans[index].name) | capitalize }} {{ plans[index].attributes.old_price | currency }} {{ plans[index].price | currency }}

All subscriptions auto renew but are easy to cancel.

I Accept The Terms Of Service

{{ registerForm.errors.get('terms') }}

Tax: {{ taxAmount(selectedPlan) | currency }}

Total Price Including Tax: {{ priceWithTax(selectedPlan) | currency }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerSeat ? '/ '+ spark.seatName : '' }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerTeam ? '/ '+ __('teams.team') : '' }} / {{ __(selectedPlan.interval) | capitalize }}

Economy

Willis to Breman: a 3am call would’ve been ‘totally fine’

Nicola Willis made the remarks immediately after the PM's State of the Nation address.

Dileepa Fonseka 4:28pm

Markets

F&P Healthcare appoints Anna Curzon

Curzon will fill the vacancy following the retirement of Pip Greenwood.

Staff reporters 9:32am

The Quiz Free

QuiznessDesk, Monday, Jan 19

Want to show your boss how clever you are?

The Quizmaster 9:15am

Sponsored

Generative AI will disrupt 90% of jobs - what it means for the future of work

Here’s what that means for the future of work in New Zealand.

Cognizant

Sponsored

AI is only as good as its data foundation

NZ leaders explain why clean, connected data drives AI value.

Cognizant

More Primary Sector

Primary Sector

Abbott Laboratories: Who is the newcomer to Pōkeno?

Synlait Milk’s loss is a US company’s gain.

Riley Kennedy 5:00am

Primary Sector

Ample Meats made to file financial accounts for first time

It operates a single plant in Taranaki.

Riley Kennedy 15 Jan 2026

Primary Sector

Construction costs rise at fastest pace in more than a year

Construction costs in the final quarter of 2025 rose at the fastest pace in more than a year, according to new data.The Cordell Construction Cost Index (CCCI) shows residential building costs increased by 0.9% in the three months to December.This was the largest quarterly rise si...

Staff reporters 14 Jan 2026

Primary Sector

Miners prosper on the NZX

In late morning trading, Manuka Resources was up 25% to 15 cents.

Ian Llewellyn 07 Jan 2026

Liquidators of biotech startup in talks over stake in drug firm

More Primary Sector

Your company has a subscription

Team